Molecular Docking Studies for the Identification of Mycobacterial Adenosine Triphosphate(ATP) Synthase Inhibitors Using Active Phytocompounds from Plants Curcuma longa,Curcuma zedoaria and Galipea officinalis

Open Access

Year : 2024 | Volume : | : | Page : –
By

Priyanka Raja

Shubham Wanarase

  1. Research Intern , Department Of Bioinformatics, BioNome, Bengaluru Karnataka India
  2. Bioinformatics Associate Department Of Bioinformatics, BioNome, Bengaluru. Karnataka India

Abstract

Objective: Tuberculosis(TB), known in human history for several decades remains the second leading infectious disease after COVID-19. Still, the occurrence of TB increases due to the bacterium’s greater survival nature. They can survive in extreme conditions by being in long latency and adapting to the host. This study seeks to identify potential inhibitors from Curcuma longa, Curcuma zeodaria and Galipea officinalis based on ancient folklore and compared against the known Mycobacterial ATP synthase inhibitor, Bedaquiline.To perform docking studies,drug-likeness and ADMET analysis.
Methods: The structure of Mycobacterial ATP synthase was retrieved from the PDB database. Preparation of protein and docking studies were performed using the PyRx tool For the drug-likeliness study, the SwissADME webserver was used. For ADMET analysis, the ADMETlab webserver was used.
Results: The docking study showed 6 potential compounds that inhibit Mycobacterial ATP synthase thereby interfering with ATP synthesis besides the known inhibitor, Bedaquiline. Among these six compounds, Cyclocurcumin, Cusparine and Galipeine had shown similar binding nature compared to that of Bedaquiline. The known inhibitor, Bedaquiline inhibits the protein by blocking the rotation of the C chain which is the catalytic headpiece. Thus it primarily inhibits the F-ATP synthesis in the bacterium.
Conclusion: Considering the drug-likeliness and ADMET analysis Galipeine shows better safety and toxicity profile than Cyclocurcumin.The study proposes Cyclocurcumin and Galipeine as potential inhibitors of Mycobacterial ATP-synthase for designing a therapeutic compound, by exploiting the phytocompounds especially known for their purpose for treating Tuberculosis based on Ancient folklore.

Keywords: Tuberculosis; Mycobacterial ATP synthase; Curcuma longa; Curcuma zeodaria; Galipea officinalis; Traditional Medicine

How to cite this article: Priyanka Raja, Shubham Wanarase. Molecular Docking Studies for the Identification of Mycobacterial Adenosine Triphosphate(ATP) Synthase Inhibitors Using Active Phytocompounds from Plants Curcuma longa,Curcuma zedoaria and Galipea officinalis. International Journal of Bioinformatics and Computational Biology. 2024; ():-.
How to cite this URL: Priyanka Raja, Shubham Wanarase. Molecular Docking Studies for the Identification of Mycobacterial Adenosine Triphosphate(ATP) Synthase Inhibitors Using Active Phytocompounds from Plants Curcuma longa,Curcuma zedoaria and Galipea officinalis. International Journal of Bioinformatics and Computational Biology. 2024; ():-. Available from: https://journals.stmjournals.com/ijbcb/article=2024/view=148204

Full Text PDF Download

References

  1. Adigun R, Singh R. Tuberculosis. StatPearls. 2023 Jul 11; Available from: https://www.statpearls.com/ArticleLibrary/viewarticle/30653#/
  2. ‌Chai Q, Zhang Y, Liu CH. Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases. Frontiers in Cellular and Infection Microbiology. 2018 May 15;8(158).
  3. ‌Shetye GS, Franzblau SG, Cho S. New tuberculosis drug targets, their inhibitors, and potential therapeutic impact. Translational Research. 2020 Mar;
  4. ‌Biuković G, Basak S, Manimekalai MSS, Rishikesan S, Roessle M, Dick T, et al. Variations of Subunit ε of the Mycobacterium tuberculosis F 1 F o ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207. Antimicrobial Agents and Chemotherapy. 2013 Jan;57(1):168–76.
  5. Preiss L, Langer JD, Yildiz Ö, Eckhardt-Strelau L, Guillemont JEG, Koul A, et al. Structure of the mycobacterial ATP synthase Forotor ring in complex with the anti-TB drug bedaquiline. Science Advances. 2015 May;1(4):e1500106.
  6. Tran SL, Cook GM. The F1Fo-ATP Synthase of Mycobacterium smegmatis Is Essential for Growth. Journal of Bacteriology [Internet]. 2005 Jul 1 [cited 2020 Apr 6];187(14):5023–8.
  7. (Bethesda, 2012)‌Widyowati R, Agil M. Chemical Constituents and Bioactivities of Several Indonesian Plants Typically Used in Jamu. Chemical and Pharmaceutical Bulletin. 2018 May1;66(5):506–18.
  8. Houghton PJ, Watabe Y, Woldemariam TZ, Yates MD. Activity of alkaloids from Angostura bark against Mycobacterium tuberculosis. Journal of Pharmacy and Pharmacology. 1998 Sep 1;50(Supplement_9):230–0.
  9. ‌Diaz G, Miranda IL, Diaz MAN. Quinolines, Isoquinolines, Angustureine, and Congeneric Alkaloids — Occurrence, Chemistry, and Biological Activity [Internet]. www.intechopen.com. IntechOpen; 2015. Available from: http://www.intechopen.com/books/phytochemicals-isolation-characterisation-and-role-in-human-health/quinolines-isoquinolines-angustureine-and-congeneric-alkaloids-occurrence-chemistry-and-biological-a
  10. Dallakyan S, Olson AJ. Small-Molecule Library Screening by Docking with PyRx. Methods in Molecular Biology. 2014 Dec 22;1263:243–50.
  11. ‌Ahmad, Z., & Laughlin, T. F. (2023). Medicinal Chemistry of ATP Synthase: A Potential Drug Target of Dietary Polyphenols and Amphibian Antimicrobial Peptides. Current Medicinal Chemistry, 17(25), 2822–2836. https://doi.org/10.2174%2F092986710791859270
  12. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. Journal of Cheminformatics. 2011 Oct 7;3(1).
  13. ‌Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. Journal of Chemical Information and Modeling. 2021 Jul 19;61(8).
  14. Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry. 2009;31(2)
  15. Daina A, Michielin O, Zoete V. SwissADME: a Free web Tool to Evaluate pharmacokinetics, drug-likeness and Medicinal Chemistry Friendliness of Small Molecules. Scientific Reports [Internet]. 2017 Mar 3;7(1). Available from: https://www.nature.com/articles/srep42717
  16. Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies. 2004 Dec;1(4):337–41.
  17. Daina A, Zoete V. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem. 2016 May 24;11(11):1117–21.
  18. Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Research [Internet]. 2021 Apr 24;49(W1):W5–14. Available from: https://academic.oup.com/nar/article/49/W1/W5/6249611?login=true
  19. ‌Savjani KT, Gajjar AK, Savjani JK. Drug solubility: Importance and enhancement techniques. ISRN Pharmaceutics [Internet]. 2012 Jul 5;2012:1–10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399483/
  20. ‌Chen C, Lee MH, Weng C, Leong MK. Theoretical Prediction of the Complex P-Glycoprotein Substrate Efflux Based on the Novel Hierarchical Support Vector Regression Scheme. Molecules [Internet]. 2018 Jul 22 [cited 2023 Oct 4];23(7):1820–0. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100076/
Ahead of Print Open Access Original Research
Volume
Received January 25, 2024
Accepted May 23, 2024
Published May 29, 2024
Views: 38